Search results for: 'revenue management ad monetization'
- Related search terms
- revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related test
- revenue opportunities in Europe Charging Infrastructure
- revenue estimator for payment fraud prevention services
- revenue estimated for payment fraud prevention services
- management services more
-
14 Feb 2025  |  Global  |  Market Research
Proteomics Research Tools and Diagnostics Market, Global, 2024-2030
The Proteomics Industry is Experiencing Transformational Growth Due to Advancements in Proteomics Profiling and Biomarker Discovery
In the study, Frost & Sullivan examines the global proteomics research tools and diagnostics market, covering different product types, end users, and technologies. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones, largely driven by the research and pharmaceutical segments. The increasing...
$4,950.00
Special Price $4,455.00 save 10 %
-
06 Jul 2017  |  Asia Pacific  |  Market Research
Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021
Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth
There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer thera...
$4,950.00
Special Price $3,712.50 save 25 %
-
18 Aug 2025  |  Global  |  Market Research
Cell Biology Research Market, Global, 2024–2030
Cell Biology Research is Experiencing Transformational Growth due to Advances in Single-Cell Technologies and Genomics Tools
In the study, Frost & Sullivan examines the global cell biology research market. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones. This growth reflects accelerating innovation across instrumentation, consumables, and software platforms, with a firm push from data-driven research models, ...
$4,950.00 -
12 Sep 2016  |  North America  |  Market Research
Analysis of US Food Intolerance and Allergy Testing Market
Explore Potential Partners and Distribution Channels to Increase Market Position in the Direct-to-Consumer Pathway
The objective of this research is to understand the food intolerance and food allergy testing market in the United States. While allergy testing is common, food intolerance testing is provided by very few manufacturers, mostly as laboratory developed tests (LDTs) in the direct-to-consumer (DTC) pathway. The study includes key profiles of food intol...
$1,500.00
Special Price $1,125.00 save 25 %
-
06 Nov 2025  |  Global  |  Market Research
Global Genetic Testing Industry, Forecast of 2025–2030
Population Screening Initiatives, Reproductive Health Demand, and Clinical Risk Stratification are Accelerating Growth in Genetic Testing, Enabled by Advancements in Sequencing Technologies and Data-Driven Interpretation
This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...
$4,950.00 -
21 Jun 2019  |  Asia Pacific  |  Market Research
Chinese In-vitro Diagnostics Market Insight, Forecast to 2023
The China Manufacturing 2025 Program for Promoting Local R&D Investments and Increasing Demand from Tier I and II Hospitals Set to Transform the Industry Landscape
The In-vitro Diagnostics (IVD) market in China shows strong growth potential in several segments. Market growth is set to be driven by the growing volume of tests, rather than the higher price of testing solutions in traditional segments and the popularization of advanced testing technology in emerging segments. In the context of the reform in publ...
$1,500.00
Special Price $1,125.00 save 25 %
-
19 Feb 2025  |  Global  |  Market Research
Antimicrobial Resistance Diagnostics Market, Global, 2024–2030
The Shift to Whole-genome Sequencing and Multiplex Point-of-care Testing is Driving Transformational Growth Due to Improved Speed, Accuracy, and High Throughput
This Frost & Sullivan report examines the antimicrobial resistance (AMR) diagnostics market in human health. AMR, characterized by bacteria, viruses, and fungi that no longer respond to antimicrobial medications, is one of the top ten global public health threats. When pathogens develop drug resistance, medications become ineffective, leading to in...
$4,950.00
Special Price $4,455.00 save 10 %
-
09 Jul 2025  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2025
Driven by Novel Biomarkers, Digital Services, and Automation, Industry is Accelerating Precision, Efficiency, and Early Disease Detection in Molecular Diagnostics and Point-of-care Testing (POCT)
The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...
$4,950.00
Special Price $4,455.00 save 10 %
-
25 May 2018  |  Europe  |  Market Research
Western European Cardiac Troponin Diagnostics Market, Forecast to 2021
Emerging Biomarkers Disrupt and Spur Growth in the Heart Disease Segment
Cardiac troponins have now become the gold standard for early diagnosis of acute myocardial infarction, making them indispensable for clinical diagnosis of Acute Coronary Syndrome (ACS). Cardiac troponins play a key role in minimizing hospital stays and reducing admission rate which are the biggest contributors to overall healthcare expenditure. Fo...
$3,000.00
Special Price $2,250.00 save 25 %
-
05 Aug 2025  |  Global  |  Market Research
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024–2030
Advances in Next-Generation Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...
$4,950.00